EraCal Therapeutics AG’s €235 Million Licensing Agreement To Novo Nordisk

VISCHER advised EraCal on all legal issues related to the transaction.EraCal Therapeutics has signed a collaboration and license agreement with Danish pharma producer Novo Nordisk. According…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Marco Zingaro

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here